Browsing Tag
National Cancer Institute
7 posts
Ovarian cancer treatment options, survival rates, and the newest FDA approvals in 2026
Ovarian cancer affects 21,000 US women annually. This guide covers symptoms, staging, survival rates, BRCA risk, and the newest FDA-approved treatments through early 2026.
PhotonPharma secures U.S. patent for cancer immunotherapy technology with potential to reshape ovarian cancer treatment
PhotonPharma secures U.S. patent for Innocell cancer vaccine tech, targeting ovarian cancer with scalable immunotherapy. See how it could reshape oncology.
Cell therapy in solid tumors: Breakthroughs, delivery challenges, and what’s next
Discover how new trials and biotech innovations are tackling the biggest hurdles in adapting cell therapy for solid tumors. See what’s changing now.
Thermo Fisher Scientific and NCI launch myeloMATCH trial to advance AML and MDS treatment
In a significant advancement in cancer treatment, Thermo Fisher Scientific Inc. (NYSE: TMO) has partnered with the National…
Oxford BioDynamics collaborates with National Cancer Institute in prostate cancer clinical trial
Oxford BioDynamics Plc (AIM: OBD), a pioneering biotechnology company, has announced its participation in a significant clinical trial…
Infosys opens rest house at National Cancer Institute in AIIMS, Jhajjar
Infosys said that its philanthropic and CSR arm — Infosys Foundation inaugurated the ‘Infosys Foundation Vishram Sadan’, a…
Spectrum Pharmaceuticals seeks FDA approval for ROLONTIS to combat chemotherapy-induced neutropenia
In a significant move within the oncology sector, Spectrum Pharmaceuticals has submitted a Biologics License Application (BLA) to…